ZD Medical Completes Nearly RMB 100 Million Series C Financing to Advance Domestic Ophthalmic Devices

Nov 05, 2024 18:33 CST Updated 18:34

ZD Medical

Developer, Manufacturer, and Supplier of Advanced Ophthalmic Medical Devices

Instrument Family

Pioneer in Medical Device Media Reports

Share Professional Medical Device Knowledge

Source: Investment Observer Health

Recently,ZhiDing Medical Technology (Hang Zhou) Co., Ltd. (hereinafter referred to as "ZD Medical") has successfully completed a nearly 100-million-yuan C-round financing.This round of financing was led by Taipo Life Science Investment, with Hancon Capital, Huiding Capital, Mifang Capital, and Yangyun Capital following suit.

ZD Medical, founded in 2015 and headquartered in Hangzhou, is a high-tech enterprise specializing in the research, production, and sales of high-precision ophthalmic optical medical devices. Established by several overseas returnee doctors, ZD Medical boasts strong research capabilities, with an optical R&D center in the United States. It gathers top talents in the optical field from both China and the U.S., forming an international team dedicated to product development, innovation, and industrial transformation.

In the field of ophthalmic medical equipment, ZD Medical has core products--Optical Coherence Tomography Angiography (OCTA), Optical Coherence Tomography (OCT), Dry Eye Comprehensive AnalyzerAnd other products, with independent innovation, are in a leading position in the industry.

As a star product of ZD Medical, the dry eye detector has achieved a significant functional breakthrough – innovativeTwo and a Half Minutes Quick Dry Eye Test Mode,While ensuring the accuracy of the test results, it greatly reduces the testing time, bringing great convenience to both patients and doctors, achieving a dual breakthrough in speed and precision for dry eye examinations.

In early October this year, the company's full-process intelligent diagnosis OCT (Basic Version): Luminor-D60M received formal approval for registration. This OCT focuses on the core needs of primary ophthalmology, aiming to help improve the diagnostic capabilities of retinal diseases in primary ophthalmic medical institutions. It is the only basic OCT in the Chinese market that features both "AI Intelligent Screening + Remote Human Image Reading."

Qichacha shows that ZD Medical has received investments from Qiming Venture Partners, Yuelu Healthcare Fund, Chongshan Capital, TF Capital, Mifang Health Fund, and Hanking Capital.

Chairman of ZD Medical, Mr. Wang Kezhi

"We are highly confident in the future development of ZD Medical. Currently, ZD Medical has entered an era of rapid growth. We will continue to uphold the spirit of hard work, efficient collaboration, practical innovation, and take the mission of safeguarding vision through technology. We are committed to becoming a leader in China-produced ophthalmic medical devices and building a strong professional team for ophthalmic equipment. Looking ahead, guided by actual medical needs, we will create high-end medical service equipment, steadily taking each step to build an ophthalmic platform enterprise. Not only will we provide top-tier equipment and services to healthcare institutions in China, but we will also contribute to improving the overall eye health standards and medical services across the country."

This round led by Taipo Life Science Investment

"Medical device companies need to have a systematic understanding of the medical technology innovation process, strong capabilities in technology productization and product scaling, and an interdisciplinary management team with expertise in engineering, medicine, management, and law. ZD Medical has accumulated research, production, and marketing experience in the ophthalmology field, possessing the foundation and capability for systematic expansion, with a distinctive team structure. We look forward to and will collaboratively support ZD Medical in leveraging its systemic advantages to efficiently identify and analyze clinical needs, continuously build a competitive technology platform and product system, thereby serving doctors and patients."

END

A-share Medical Device Leader, Sells This Business for 634 Million

Preview of CIIE: "Black Technology" in Surgical Instruments

Zhangjiang Group Increases Investment in This Ultrasound Research Institute

Stock Price Drops 16%, Philips CEO: China Will Come Back

Preview of CIIE: "Black Technology" in Medical Imaging

Midea Invests, Chinese-Made Surgical Robot Company Dissolves One Firm

Top 100 Medical Device Companies Build New Headquarters

650,000 Products Recalled, Orthopedic Leader Declares Bankruptcy

Philips: Layoffs, This Business Transfer

Medtronic Officially Announces a Chief Medical Officer from Cleveland Clinic

BusinessBusiness cooperation email: qxzj@landianyiliao.com